title: [Ipilimumab-induced hypophysitis].
authors.forename: S
authors.initials: S
authors.lastname: Schleder
authors.forename: S
authors.initials: S
authors.lastname: Schreml
authors.forename: P
authors.initials: P
authors.lastname: Heiss
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007262:Infusions, Intravenous; D000074324:Ipilimumab; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D008875:Middle Aged; D009367:Neoplasm Staging; D010900:Pituitary Diseases / Q000139:chemically induced* / Q000175:diagnosis; D010902:Pituitary Gland / Q000187:drug effects*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab